New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
16:56 EDTDIS, CALX, GME, RS, BIIB, CHRW, TTWO, MUSA, ELN, MSFT, SFLY, BIOLOn The Fly: Closing Wrap
Stocks on Wall Street were mixed as the averages moved in a tighter range than they had during the first two trading sessions of the week. A quiet economic calendar, a light news flow and modest trading volume resulted in a quieter day for the market... ECONOMIC EVENTS: In the U.S., the Department of Energy reported that crude supplies grew by 2.62M barrels, roughly in-line with forecasts. In Japan, the governor of its central bank offered to step down three weeks before the end of his term, fueling speculation that accelerated and more aggressive stimulus measures may follow and sparking a 3.8% run-up in the Nikkei average... COMPANY NEWS: Dow component Walt Disney (DIS) opened the session at all time highs after the company's quarterly results beat consensus estimates. Citigroup also raised its price target on Disney stock to $63 from $54, but shares finished off their early highs, up 23c, or 0.42%, to $54.52... Elan (ELN) shares slid $1.06, or 10.13%, to $9.40 after the company agreed to sell its 50% interest in the Tysabri multiple sclerosis drug to Biogen (BIIB) for $3.25B in cash and future royalty payments. Biogen shares rose $3.62, or 2.3%, to $160.98 following the announcement... MAJOR MOVERS: Among the notable gainers was BIOLASE (BIOL), up 55c, or 19.43%, to $3.38 after receiving FDA clearance for a soft tissue laser device. Also higher was Metals USA (MUSA), up $2.35, or 12.84%, to $20.65 after agreeing to be acquired by Reliance Steel (RS) for $20.65 per share. Reliance steel also gained $5.56, or 8.59%, to $70.25 following the news. Among those trading higher after earnings were Shutterfly (SFLY), up $6.81, or 20.27%, to $40.40 and Take-Two Interactive (TTWO), up $1.78, or 14.06%, to $14.44. Among the noteworthy losers was GameStop (GME), down $1.61, or 6.01%, to $25.20 following a report suggesting the next version of Microsoft's (MSFT) Xbox video game system will not allow used games to be resold. Among those trading lower after earnings were C.H. Robinson (CHRW), down $6.51, or 9.71%, to $60.50 and Calix (CALX), down 83c, or 9.75%, to $7.68... INDICES: The Dow was up 7.22, or 0.05%, to 13,986.52; the Nasdaq was down 3.10, or 0.10%, to 3,168.48; and the S&P 500 was up 0.83, or 0.05%, to 1,512.12.
News For DIS;ELN;BIIB;BIOL;MUSA;RS;SFLY;TTWO;GME;MSFT;CHRW;CALX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 26, 2015
14:02 EDTMSFTMicrosoft shutting down two factories in China, Want China Times reports
Subscribe for More Information
12:48 EDTDISEarnings Preview: J.C. Penney sees Q4 SSS at high end of 2%-4% view
Subscribe for More Information
10:42 EDTGMEGameStop wins bid for 150 RadioShack stores, says BofA/Merrill
Subscribe for More Information
08:15 EDTBIIBBiogen shares likely to continue to advance, says RBC Capital
Subscribe for More Information
06:27 EDTMSFTMicrosoft increases orders to China makers, DigiTimes reports
Microsoft is increasing orders to China makers and away from Taiwan makers, reports DigiTimes. Microsoft has become increasingly concerned over costs and is adjusting its supply chain to receive components at more competitive pricing that previously received from Taiwan makers. Reference Link
06:13 EDTMSFTStocks with implied volatility below IV index mean; MSFT QCOM
Subscribe for More Information
February 25, 2015
13:02 EDTGMERadioShack delays sale of stores, GameStop expresses interest, Reuters says
Subscribe for More Information
11:47 EDTDISAnalysts clash on DreamWorks following Q4 miss
The shares of animated film and television show maker DreamWorks (DWA) are rising, despite the weaker than expected results reported by the company last night. Two analysts offered very different views on the company's outlook following its results. BACKGROUND: DreamWorks last night reported a fourth quarter per share loss of ($3.08), versus analysts' consensus outlook for a ($3.01) per share loss. The company's revenue also came in below expectations. Excluding $210M in pre-tax charges associated with DreamWorks' restructuring plan, its loss was (75c) per share, the company stated. BEARISH TAKE: In a note to investors today, FBR Capital analyst Barton Crockett wrote that DreamWorks' results were "ugly," as they included $155M of write-offs on films and TV shows. However, Crockett believes that the crucial factor for the company's outlook is whether it can consistently compete with the entertainment giants, including Disney (DIS), Viacom (VIA), and Time Warner (TWX). Crockett is not convinced that DreamWorks will be able to hold its own, and he believes that its 2015 results could come in below expectations. The analyst warned that the company may have difficulty meeting its 2015 consumer products revenue guidance. DreamWorks expects its consumer products revenue to double this year, but the movie-based toy space is "very competitive" in 2015, as toys based on multiple popular children's films are set to be released, Crockett stated. Moreover, after conducting checks online, Crockett reports that there does not seem to be a great deal of interest in DreamWorks' movie "Home," which is set to be released on March 27. He kept an Underperform rating on the shares and raised his price target on the stock to $14 from $12. BULLISH TAKE: DreamWorks' results were mixed, but the results are not very important, Piper Jaffray analyst James Marsh stated. The company's guidance for its TV and consumer products businesses were solid, the analyst believes. Moreover, the company "took specific and decisive action" to avert a liquidity crunch, Marsh wrote. Specifically, DreamWorks raised $185M of capital by selling its real estate in Glendale, California and then leasing it back, and increased the size of its current credit facility to $450M from $400M, Marsh reported. The moves should "largely" eliminate investors' worries about the company's liquidity position, Marsh stated. He kept a $26 price target and Overweight rating on the stock. WHAT'S NOTABLE: On DreamWorks' earnings conference call last night, the company's CEO Jeffrey Katzenberg stated that it did not obtain more than 10% of its revenue from Netflix (NFLX) last year. However, in an SEC filing earlier this morning, DreamWorks clarified that it had obtained 14.9% of its revenue from Netflix last year. PRICE ACTION: In late morning trading, DreamWorks rose 5.6% to $22.31.
10:34 EDTMSFTHP slide after currency driven guidance cut called buying opportunity
The shares of Hewlett-Packard (HPQ) are falling after the company reported lower than expected first quarter revenue and sharply lowered its free cash flow guidance and cut its fiscal year profit view. However, analysts at Citigroup, Bernstein, and Brean Capital all recommended buying the stock on weakness in separate notes to investors today. BACKGROUND: HP reported slightly higher than expected Q1 profits, but its revenue came in below expectations. The company sharply lowered its fiscal 2015 free cash flow guidance to $3.5B-$4B from its previous outlook of $6.5B-$7B. The tech giant also lowered its fiscal 2015 EPS guidance to $3.53-$3.73 from its previous outlook of $3.83-$4.30. "While we were able to manage the impact of currency in the quarter and deliver earnings as expected, we believe the impact on FY15 will be significantly greater than we anticipated in November. We'll work hard to offset these impacts through re-pricing and productivity, but fully mitigating currency movements of this size would require reducing investments and mortgaging our future. We won't do that," said HP CEO Meg Whitman. ANALYST REACTION: The decline in HP's EPS guidance was entirely due to foreign currency fluctuations, while most of the cut in its free cash flow guidance was caused by one-time costs related to the upcoming split of HP into two separate companies, Citi analyst Jim Suva stated. Most of the company's businesses "continue to perform well or at least make progress," wrote Suva. The decline in the stock has created an attractive entry point for investors who are looking to own the shares in order to benefit from the break-up, according to the analyst. He kept a Buy rating on the shares. Bernstein analyst A.M. Sacconaghi was less upbeat on HP's outlook, but also recommended buying the shares on today's weakness. Although revenue estimates for HP may be too high, the stock's valuation remains attractive, as it is the second least expensive tech stock in the S&P 500, according to Sacconaghi, who believes the shares are worth $45-$50. Cautioning that HP's stock is likely "to be in the penalty box" in the near-term, Sacconaghi nonetheless believes that the shares could get a significant boost when the company provides more information about its spin-off. He recommended that investors buy the stock on today's weakness and kept an Outperform rating on the shares. HP's fundamentals haven't changed, as the company continues to expect its revenue to remain flat in fiscal 2015, and it has not changed its capital return guidance, Brean Capital analyst Ananda Baruah stated. The company also continues to expect free cash flow of at least $5B-$6B in 2016 and beyond, Baruah added. Moreover, HP's share repurchases are unlikely to be significantly reduced as a result of the decline in its free cash flow guidance, the analyst predicted. Baruah recommended buying the stock on today's weakness and kept a $45 price target and Buy rating on the shares. PRICE ACTION: In early trading, HP fell 9.5% to $34.84. OTHERS TO WATCH: Other large cap PC levered names are also weak in morning trading after HP's report last night, with Microsoft (MSFT) down 0.25% and Intel (INTC) down 1.2%.
09:48 EDTMSFTIDC reports 96.3% smartphone marketshare for iPhone, Android
Subscribe for More Information
06:14 EDTBIIBPTC Therapeutics takeout price likely tops $100/share, said Credit Suisse
Credit Suisse yesterday raised its price target for PTC Therapeutics (PTCT) shares to $100 from $66 after Reuters reported the drug market is starting a sale process with Shire (SHPG) and Biomarin (BMRN) as possible suitors. The firm believes a takeout is a likely outcome before or after data the Phase III data expected to be announced in October. PTC has Translarna Phase III trials ongoing in Duchenne muscular dystrophy and cystic fibrosis to support full approval in the U.S. Credit Suisse said yesterday in a note to investors that a takeout value for the company likely exceeds $100 per share. It believes PTC would be a good fit for Vertex (VRTX), Biogen (BIIB), Roche (RHHBY) and others. The firm kept an Outperform rating on the stock. PTC Therapeutics shares closed yesterday up $6.20 to $71.16.
05:54 EDTMSFTStocks with implied volatility below IV index mean; FOSL QCOM
Subscribe for More Information
February 23, 2015
18:13 EDTDISBob Chapek named Chairman, Walt Disney Parks and Resorts
Bob Chapek has been named Chairman, Walt Disney Parks and Resorts, it was announced by Robert A. Iger, Chairman and CEO, and Thomas O. Staggs, COO, The Walt Disney Company. A 22-year veteran of The Walt Disney Company, Chapek has served since 2011 as President of Disney Consumer Products, driving a technology-led transformation of the company’s consumer products, retail and publishing operations. He assumes his new role effective immediately.
11:35 EDTDISAmazon picks Benson to head advertising for original TV series, Variety says
Subscribe for More Information
February 22, 2015
13:03 EDTDISDisney raises prices at the Magic Kingdom, Orlando Sentinel says
Subscribe for More Information
February 20, 2015
13:08 EDTTTWOTake-Two management to meet with MKM Partners
Meeting to be held in New York on February 27 hosted by MKM Partners.
10:01 EDTRSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:51 EDTRSReliance Steel has reached attractive entry point, says Wells Fargo
After Reliance Steel reported results that Wells Fargo views as disappointing, the firm nonetheless says that the shares are "too cheap to ignore." The firm thinks the stock has reached an attractive entry point for long-term investors, and it keeps an Outperform rating on the shares.
07:05 EDTRSReliance Steel upgraded at KeyBanc
As previously reported, KeyBanc upgraded Reliance Steel to Buy from Hold. Following yesterday's earnings report, the firm believes Reliance is near a trough in the earnings cycle, has compelling free-cash-flow to support accretive capital deployments, and has one of the strongest managements in the industry. Price target is $66.
06:02 EDTRSReliance Steel upgraded to Buy from Hold at KeyBanc
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use